Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
8 pending office actions • 6 clients • 8 examiners • 5 art units • 0 of 8 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Syndicated Law PC focuses on Biotechnology & Pharmaceuticals with 388 career applications. The firm has a resolved allowance rate pct of 90.42. This rate indicates the percentage of resolved cases that have been allowed, providing a measure of historical outcomes for its 388 career applications.
The firm averages 2.79 office actions per allowance, representing the typical procedural path to a patent grant. There are 7 pending office actions currently on the docket. This current activity is part of the firm's history in Biotechnology & Pharmaceuticals and reflects its ongoing prosecution work.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (12%) |
| §112 only | 1 (12%) |
| Double-patenting + other | 1 (12%) |
| Multi-statute (no §101) | 4 (50%) |
| No statute on record | 1 (12%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MERCADO VARGAS, ARIEL | 1 | 71.8% | +28.4% |
| COX, NATISHA D | 1 | 72.9% | +21.4% |
| BRANDSEN, BENJAMIN MICHAEL | 1 | 60.2% | +18.6% |
| TAKENAKA, RISA | 1 | 27.3% | +100.0% |
| HIBSHMAN, SARAH GRACE | 1 | 38.9% | +40.0% |
| TINSLEY, BRENDAN THOMAS | 1 | 58.7% | +73.9% |
| ROGERS, ERIC JASON | 1 | 57.4% | +32.6% |
| PENNINGTON, KATIE LEIGH | 1 | 29.7% | +60.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17800307 | METHOD FOR CULTURING CELLS DERIVED FROM EPITHELIAL TISSUE, AND COMPOSITION CONTAINING CELLS CULTURED BY SAID CULTURE METHOD | ROGERS, ERIC JASON | 112d overdue |
| 18561083 | METHOD FOR PRODUCING BETA-1,3-1,6-GLUCAN | BRANDSEN, BENJAMIN MICHAEL | — |
| 18027892 | CELL POPULATION PRODUCTION METHOD | TAKENAKA, RISA | — |
| 18001994 | BETA-GLUCAN FOR IMMUNO-ENHANCEMENT AND/OR IMMUNO-BALANCING, AND FOR ADJUVANT USE | HIBSHMAN, SARAH GRACE | — |
| 17801102 | BIOMATERIAL PRESERVING COMPOSITION | TINSLEY, BRENDAN THOMAS | — |
| 17601861 | CHONDROCYTE CULTURE WITH HIGH TISSUE REGENERATION ABILITY | PENNINGTON, KATIE LEIGH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17800307 | METHOD FOR CULTURING CELLS DERIVED FROM EPITHELIAL TISSUE, AND COMPOSITION CONTAINING CELLS CULTURED BY SAID CULTURE METHOD | ROGERS, ERIC JASON | 112d overdue |
| 18766372 | Systems and Methods for Assembling Remote Members of an Online Gaming Environment for a Group Interaction | COX, NATISHA D | 70d |
| 18780967 | USING A PACE SETTING PERFORMANCE TO ASSEMBLE A PLURALITY OF PERFORMANCES RECEIVED FROM REMOTE LOCATIONS | MERCADO VARGAS, ARIEL | — |
| 18561083 | METHOD FOR PRODUCING BETA-1,3-1,6-GLUCAN | BRANDSEN, BENJAMIN MICHAEL | — |
| 18027892 | CELL POPULATION PRODUCTION METHOD | TAKENAKA, RISA | — |
| 18001994 | BETA-GLUCAN FOR IMMUNO-ENHANCEMENT AND/OR IMMUNO-BALANCING, AND FOR ADJUVANT USE | HIBSHMAN, SARAH GRACE | — |
| 17801102 | BIOMATERIAL PRESERVING COMPOSITION | TINSLEY, BRENDAN THOMAS | — |
| 17601861 | CHONDROCYTE CULTURE WITH HIGH TISSUE REGENERATION ABILITY | PENNINGTON, KATIE LEIGH | — |
| Client (Assignee) | Pending OAs |
|---|---|
| GN Corporation Co Ltd | 3 |
| Jammit, Inc. | 1 |
| Turion Corporation | 1 |
| NATIONAL UNIVERSITY CORPORATION KOCHI UNIVERSITY | 1 |
| Sophy Inc. | 1 |
| Jbm Incorporation | 1 |
| Art Unit | Apps |
|---|---|
| 1693 | 2 |
| 1634 | 2 |
| 2458 | 1 |
| 1632 | 1 |
| 1638 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18780967 | USING A PACE SETTING PERFORMANCE TO ASSEMBLE A PLURALITY OF PERFORMANCES RECEIVED FROM REMOTE LOCATIONS | Jammit, Inc. | MERCADO VARGAS, ARIEL | §112DP | Non-Final OA | — | Pending | Jul 23, 2024 | |
| 18766372 | Systems and Methods for Assembling Remote Members of an Online Gaming Environment for a Group Interaction | Turion Corporation | COX, NATISHA D | 2458 | §112 | Non-Final OA | 70d | Pending | Jul 08, 2024 |
| 18561083 | METHOD FOR PRODUCING BETA-1,3-1,6-GLUCAN | National University Corporation Kochi University | BRANDSEN, BENJAMIN MICHAEL | 1693 | §101§102§112DP | Non-Final OA | — | Pending | Nov 15, 2023 |
| 18027892 | CELL POPULATION PRODUCTION METHOD | Gn Incorporation Co. Ltd. | TAKENAKA, RISA | 1632 | §102§103§112 | Final Rejection | — | Pending | Mar 22, 2023 |
| 18001994 | BETA-GLUCAN FOR IMMUNO-ENHANCEMENT AND/OR IMMUNO-BALANCING, AND FOR ADJUVANT USE | Sophy Inc. | HIBSHMAN, SARAH GRACE | 1693 | §102§103§112 | Final Rejection | — | Pending | Dec 15, 2022 |
| 17801102 | BIOMATERIAL PRESERVING COMPOSITION | Gn Corporation Co. Ltd. | TINSLEY, BRENDAN THOMAS | 1634 | §102§103§112 | Final Rejection | — | Pending | Aug 19, 2022 |
| 17800307 | METHOD FOR CULTURING CELLS DERIVED FROM EPITHELIAL TISSUE, AND COMPOSITION CONTAINING CELLS CULTURED BY SAID CULTURE METHOD | Gn Corporation Co. Ltd. | ROGERS, ERIC JASON | 1638 | §102§112 | Final Rejection | 112d overdue | Pending | Aug 17, 2022 |
| 17601861 | CHONDROCYTE CULTURE WITH HIGH TISSUE REGENERATION ABILITY | Jbm Incorporation | PENNINGTON, KATIE LEIGH | 1634 | Other | Non-Final OA | — | Pending | Oct 06, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial